Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03089839
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
ZMP | ({(3S)-3-hydroxy-2,2-dimethyl-4- oxo-4-[(3-oxo-3-{[2-(tetradecanoylsulfanyl)ethyl]amino}propyl)amino]butyl}oxy)(oxo)phosphoniumolate | A,B,C,D,E,F, G,H | 3EJB | 0.71 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 2BJS | 0.7 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1QJE | 0.7 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BK0 | 0.7 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BLZ | 0.7 | |
PAU | PANTOTHENOIC ACID | A,B | 2F9W | 0.83 | |
PAU | PANTOTHENOIC ACID | A,B,C,D,E,F | 3BF1 | 0.83 | |
PAU | PANTOTHENOIC ACID | A,B,C,D | 1SQ5 | 0.83 | |
PAU | PANTOTHENOIC ACID | A,B,C,D,E,F | 3BEX | 0.83 | |
SXM | 3-{[2-({N-[(2S)-2-hydroxy-3,3-dimethyl- 4-(phosphonooxy)butanoyl]-beta- alanyl}amino)ethyl]sulfanyl}-3- oxopropanoic acid | A | 2KG8 | 0.79 | |
PN2 | A,D,E,F | 1F80 | 0.79 | ||
SXA | THIOACETIC ACID S-{2-[3-(2-HYDROXY- 3,3-DIMETHYL-4-PHOSPHONOOXY-BUTYRYLAMINO)- PROPIONYLAMINO]-ETHYL} ESTER | A | 2KG6 | 0.79 | |
PN5 | (3R)-3-hydroxy-2,2-dimethyl-4-oxo- 4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2- dimethylpropanoate | A,B | 2VU2 | 0.91 | |
SMG | N-SUCCINYL METHIONINE | A,B,C,D | 1SJC | 0.73 | |
MDZ | N~6~-METHYL-6-OXO-L-LYSINE - 2- [(3-MERCAPTOBUTANOYL)OXY]-3-METHYLBUTANOIC ACID | A | 1W3V | 0.73 | |
SXO | S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl- 4-(phosphonooxy)butanoyl]-beta- alanyl}amino)ethyl] octanethioate | A | 2KGC | 0.71 | |
PSR | THIOBUTYRIC ACID S-{2-[3-(2-HYDROXY- 3,3-DIMETHYL-4-PHOSPHONOOXY-BUTYRYLAMINO)- PROPIONYLAMINO]-ETHYL} ESTER | A | 1L0I | 0.78 | |
PSR | THIOBUTYRIC ACID S-{2-[3-(2-HYDROXY- 3,3-DIMETHYL-4-PHOSPHONOOXY-BUTYRYLAMINO)- PROPIONYLAMINO]-ETHYL} ESTER | A | 2KG9 | 0.78 | |
PNS | 4'-PHOSPHOPANTETHEINE | A,B | 1QJC | 0.84 | |
PNS | 4'-PHOSPHOPANTETHEINE | A | 2FVA | 0.84 | |
PNS | 4'-PHOSPHOPANTETHEINE | A,B,C,D,E,F | 1VLH | 0.84 | |
PNS | 4'-PHOSPHOPANTETHEINE | A | 2KJS | 0.84 | |
PNS | 4'-PHOSPHOPANTETHEINE | A | 1OD6 | 0.84 | |
PNS | 4'-PHOSPHOPANTETHEINE | A,B | 3GZM | 0.84 | |
PNS | 4'-PHOSPHOPANTETHEINE | A | 2FQ2 | 0.84 | |
PNS | 4'-PHOSPHOPANTETHEINE | A | 2FVF | 0.84 | |
PNS | 4'-PHOSPHOPANTETHEINE | A,B | 1H1T | 0.84 | |
PNS | 4'-PHOSPHOPANTETHEINE | A | 2K0X | 0.84 | |
PNS | 4'-PHOSPHOPANTETHEINE | A | 2FQ0 | 0.84 | |
PNS | 4'-PHOSPHOPANTETHEINE | A | 3GZL | 0.84 | |
PAZ | N-[(2R)-2-hydroxy-3,3-dimethyl- 4-(phosphonooxy)butanoyl]-beta- alanine | A,B,C,D,E,F | 3BF3 | 0.76 | |
SXD | N-{2-[(3,5-dioxohexyl)sulfanyl]ethyl}- N~3~-[(2S)-2-hydroxy-3,3-dimethyl- 4-(phosphonooxy)butanoyl]-beta- alaninamide | A | 2KGE | 0.73 | |
ACW | D-(L-A-AMINOADIPOYL)-L-CYSTEINYL- B-METHYL-D-CYCLOPROPYLGLYCINE | B | 2IVI | 0.71 | |
PM4 | S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}- 3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEXANETHIOATE | A,B | 2FAC | 0.74 | |
PM5 | S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}- 3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEPTANETHIOATE | A,B | 2FAD | 0.72 | |
SXH | S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl- 4-(phosphonooxy)butanoyl]-beta- alanyl}amino)ethyl] hexanethioate | A | 2KGA | 0.73 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PPP | 0.76 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PE6 | 0.76 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1ITO | 0.76 | |
ATI | N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID | A | 1Y0Y | 0.71 | |
PM8 | S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}- 3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) DECANETHIOATE | A,B | 2FAE | 0.71 | |
OCV | N6-[(1R)-2-{[(1R)-1-CARBOXY-2-METHYLPROPYL]OXY}- 1-(MERCAPTOMETHYL)-2-OXOETHYL]- 6-OXO-D-LYSINE | A | 1HB1 | 0.73 | |
PCO | 2,4-DIHYDROXY-N-[2-(2-MERCAPTO- VINYLCARBAMOYL)-ETHYL]-3,3-DIMETHYL- BUTYRAMIDE | A | 1MVN | 0.84 | |
THC | N-METHYLCARBONYLTHREONINE | A,B,C | 1A7C | 0.71 | |
THC | N-METHYLCARBONYLTHREONINE | B | 2HR0 | 0.71 | |
THC | N-METHYLCARBONYLTHREONINE | L,P | 2MPA | 0.71 | |
THC | N-METHYLCARBONYLTHREONINE | L,P | 1MPA | 0.71 | |
SXV | N~3~-[(2S)-2-hydroxy-3,3-dimethyl- 4-(phosphonooxy)butanoyl]-N-{2- [(3-oxobutyl)sulfanyl]ethyl}-beta- alaninamide | A | 2KGD | 0.77 | |
168 | PANTOTHENYL-AMINOETHANOL-ACETATE PIVALIC ACID | A,B,C,D | 1OU6 | 0.81 | |
OPI | PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID | A,B,C,D | 2VU1 | 0.83 | |
M11 | N^6^-[(1R,2S)-1-({[(1R)-1-carboxy- 2-methylpropyl]oxy}carbonyl)-2- sulfanylpropyl]-6-oxo-L-lysine | A | 2VE1 | 0.73 | |
M11 | N^6^-[(1R,2S)-1-({[(1R)-1-carboxy- 2-methylpropyl]oxy}carbonyl)-2- sulfanylpropyl]-6-oxo-L-lysine | A | 2VCM | 0.73 | |
CYK | N-hexanoyl-L-homocysteine | A | 3DHC | 0.71 |